Hsbc Holdings PLC raised its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 497.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,886 shares of the health services provider’s stock after buying an additional 11,563 shares during the quarter. Hsbc Holdings PLC’s holdings in Maximus were worth $1,205,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in MMS. Royal Bank of Canada lifted its holdings in shares of Maximus by 146.2% in the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock valued at $1,345,000 after purchasing an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after purchasing an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Maximus by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock valued at $12,321,000 after purchasing an additional 11,754 shares during the period. Jane Street Group LLC lifted its position in shares of Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock worth $6,701,000 after purchasing an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Maximus during the second quarter worth approximately $204,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have issued reports on MMS. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Finally, Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold”.
Maximus Stock Performance
Shares of NYSE MMS opened at $56.63 on Monday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. The firm has a market cap of $2.98 billion, a price-to-earnings ratio of 8.48 and a beta of 0.60. The business’s 50-day simple moving average is $59.51 and its 200-day simple moving average is $71.70. Maximus, Inc. has a 52 week low of $52.73 and a 52 week high of $100.00.
Maximus (NYSE:MMS – Get Free Report) last posted its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same period in the previous year, the company earned $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, equities research analysts expect that Maximus, Inc. will post 8.43 earnings per share for the current fiscal year.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 14th. Maximus’s payout ratio is presently 19.76%.
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Stories
- Five stocks we like better than Maximus
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
